These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1241970)
1. Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction. Schwope AD; Wise DL; Howes JF Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):13-8. PubMed ID: 1241970 [TBL] [Abstract][Full Text] [Related]
2. Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction. Schwope AD; Wise DL; Howes JF Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):13-8. PubMed ID: 787798 [TBL] [Abstract][Full Text] [Related]
3. Development of drug delivery systems for use in treatment of narcotic addiction. Sharon AC; Wise DL NIDA Res Monogr; 1981; 28():194-213. PubMed ID: 6791005 [TBL] [Abstract][Full Text] [Related]
4. Development of injectable microcapsules for use in the treatment of narcotic addiction. Thies C Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):19-20. PubMed ID: 1241971 [TBL] [Abstract][Full Text] [Related]
5. Testing of drug delivery systems for use in the treatment of narcotic addiction. Reuning RH; Malspeis L; Frank S; Notari RE Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):43-5. PubMed ID: 827709 [TBL] [Abstract][Full Text] [Related]
6. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists. Sidman KR; Arnold DL; Steber WD; Nelsen L; Granchelli FE; Strong P; Sheth SG Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):33-8. PubMed ID: 1234983 [TBL] [Abstract][Full Text] [Related]
7. Development of Chronomers for narcotic antagonists. Capozza RC; Schmitt EE; Sendelbeck LR Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):39-42. PubMed ID: 13306 [TBL] [Abstract][Full Text] [Related]
8. Sustained release of naltrexone from glyceride implants. Sullivan MF; Kalkwarf DR Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):27-32. PubMed ID: 967232 [TBL] [Abstract][Full Text] [Related]
9. Sustained release of naltrexone from glyceride implants. Sullivan MF; Kalkward DR Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):27-32. PubMed ID: 1234982 [TBL] [Abstract][Full Text] [Related]
10. A review of parenteral sustained-release naltrexone systems. Olsen JL; Kincl FA NIDA Res Monogr; 1981; 28():187-93. PubMed ID: 6791004 [TBL] [Abstract][Full Text] [Related]
11. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists. Sidman KR; Arnold DL; Steber WD; Nelsen L; Granchelli FE; Strong P; Sheth SG Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):33-8. PubMed ID: 967233 [TBL] [Abstract][Full Text] [Related]
12. Development of injectable microcapsules for use in the treatment of narcotic addiction. Thies C Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):19-20. PubMed ID: 967230 [TBL] [Abstract][Full Text] [Related]
14. Development of Chronomers tm for narcotic antagonists. Capozza RC; Schmitt EE; Seńdelbeck LR Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):39-42. PubMed ID: 967234 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic quantitation of naltrexone release from several sustained-release delivery systems. Reuning RH; Liao SH; Staubus AE NIDA Res Monogr; 1981; 28():172-84. PubMed ID: 6791003 [TBL] [Abstract][Full Text] [Related]
16. An improved long-acting delivery system for narcotic antagonists. Misra AL; Pontani RB NIDA Res Monogr; 1981; 28():254-64. PubMed ID: 6791009 [TBL] [Abstract][Full Text] [Related]
17. Use of synthetic polypeptides in the preparation of biodegradable delivery systems for narcotic antagonists. Sidman KR; Schwope AD; Steber WD; Rudolph SE NIDA Res Monogr; 1981; 28():214-31. PubMed ID: 6791006 [TBL] [Abstract][Full Text] [Related]
18. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice. He GA; Hou HM; Liu XJ Acta Pharmacol Sin; 2001 Jun; 22(6):530-3. PubMed ID: 11747760 [TBL] [Abstract][Full Text] [Related]
19. Testing of drug delivery systems for use in the treatment of narcotic addiction. Reuning RH; Malspeis L; Frank S; Notari RE Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):43-5. PubMed ID: 823438 [TBL] [Abstract][Full Text] [Related]
20. The development of sustained action preparations of narcotic antagonists. Willette RE NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109 [No Abstract] [Full Text] [Related] [Next] [New Search]